Center for Outcomes Research in Liver Diseases | COR-LD

Our Purpose

The Center for Outcomes Research in Liver Diseases (COR-LD) has pioneered in outcomes research related to the areas of patient-reported outcomes (PROs), economic analysis, large database analysis, systematic reviews and meta-analysis involving different types of liver diseases. Additionally, COR-LD manages the Global NASH Council, the Global Liver Registry and the Global NASH Registry.

About Us

The Global NASH Council™

Non-alcoholic steatohepatitis (NASH) is increasingly recognized is one of the most common causes of liver disease worldwide. In order to understand the global impact of this disease, The Global NASH Council was created to include renowned experts from different regions of the world with interest in NASH to collaborate and exchange their views about NASH. The Global NASH Council include 41 countries from all the continents across the globe with 110 members. Members of the Council carry out collaborative projects to better understand the burden of NASH across the world.

Learn More

The Global NASH and Liver Registries

The Global NASH Registry™ and The Global Liver Registry™ are collaborative efforts led by members of the Global NASH Council. These Registries are developed to collect clinical data, laboratory data and PRO data for patients with NASH, HBV and HCV from different regions of the world. Inclusion into these Registries requires collection of the data after informed consent. Data is entered through secure cloud platform into a central secured database managed by GNC. The information in the Registries is completely de-identified and HIPAA compliant. These Registries include sites from North America, Europe, Asia, Middle East, North Africa and Australia. The ultimate goals of these registries are to obtain real world clinical and PRO data about patients with the most common causes of liver disease from different regions of the world. This data will inform us about the similarities and differences of these important liver diseases across the globe.

Learn More

Our PRO Questionnaires

Members of COR-LD are leaders in developing and validating quality of life instruments, and performing PRO data analysis for patients with liver disease. Since mid-1990s, the team has developed and validated a number of disease-specific health-related quality of life instruments for liver disease such as Chronic Liver Disease Questionnaire (CLDQ) and its hepatitis C (CLDQ-HCV) and NASH (CLDQ-NASH) versions.

More Details

Our Services

Quality of Life Questionnaires

Patient Reported Outcomes Data Analysis

Economic Analysis

Global NASH Council

Global Liver Registry